...
首页> 外文期刊>BMC Biochemistry >Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity
【24h】

Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity

机译:磷酸化促进的磺酰化MEF2C负调控其转录活性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background:Sumoylation has emerged as an important posttranslational regulatory mechanism for transcription factors and cofactors.Sumoylation of many transcription factors represses their transcriptional activities.The myocyte enhancer factor 2(MEF2)family of transcription factors plays an important role in regulating gene expression during myogenesis and has been recently shown to be sumoylated. Results:Consistent with earlier reports,we show that sumoylation of MEF2C at K391 inhibits its transcriptional activity.Sumoylation of MEF2C does not block its DNA-binding activity.A small C- terminal fragment of MEF2C containing K391,referred to as delta-N2-MEF2C,is efficiently sumoylated and,when targeted to DNA,represses transcription at neighbouring promoters. Because delta-N2-MEF2C lacks the binding site for class II histone deacetylases(HDACs),this result suggests that sumoylation of MEF2C may help to recruit transcriptional repressors other than these HDACs.Intriguingly,we show that phosphorylation of S396 in MEF2C,a residue in close proximity to the major sumoylation site(K391)and known to be phosphorylated in vivo,enhances sumoylation of delta-N2-MEF2C in vitro.The S396A mutation reduces sumoylation of MEF2C in vivo and enhances the transcription activity of MEF2C in reporter assays. Conclusion:We propose that phosphorylation of MEF2C at S396 facilitates its sumoylation at K391,which in turn recruits yet unidentified co-repressors to inhibit transcription.Our studies further suggest that sumoylation motifs containing a phosphorylated serine or an acidic residue at the+5 position might be more efficiently sumoylated.
机译:背景:磺酰化已成为转录因子和辅因子的重要翻译后调控机制,许多转录因子的磺酰化抑制了它们的转录活性。转录因子的心肌细胞增强因子2(MEF2)家族在调控成肌过程中的基因表达中起着重要作用。最近显示已被磺酰化。结果:与较早的报道一致,我们表明MEF2C在K391上的磺酰化抑制了其转录活性。MEF2C的磺酰化并未阻止其DNA结合活性。MEF2C的一个小的K末端片段包含K391,称为δ-N2- MEF2C被有效地磺酰化,当靶向DNA时,可抑制邻近启动子的转录。由于delta-N2-MEF2C缺乏II类组蛋白脱乙酰基酶(HDACs)的结合位点,因此该结果表明MEF2C的磺酰化可能有助于募集除这些HDACs以外的转录阻遏物。 S396A突变可减少delf-N2-MEF2C在体外的磺酰化作用.S396A突变可减少MEF2C在体内的磺酰化作用并增强MEF2C的转录活性。结论:我们认为MEF2C在S396处的磷酸化有助于其在K391处的磺酰化,这反过来招募了尚未鉴定的共阻遏物来抑制转录。我们的研究进一步表明,在+5位上含有磷酸化丝氨酸或酸性残基的磺酰化基序可能被更有效地磺化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号